Interstitial Cystitis: Clinical Trials

5 trials for Interstitial Cystitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 23Completed 3

Follow Interstitial Cystitis: new trials by email Literature Review of Interstitial Cystitis trials Research Report on Interstitial Cystitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PK and Safety of SI-722 in IC/BPS
SI-722, Placebo - Interstitial Cystitis, Bladder Pain Syndrome
Phase 1 / Phase 2CompletedSeikagaku Corporation332020-03-302023-12-29
Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients
TC-3 Gel mixed with Botox (BTX) - Interstitial Cystitis, IC
Phase 1 / Phase 2CompletedUroGen Pharma Ltd.152013-11-012016-04-12
Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome
TTI-1612 - Interstitial Cystitis
Phase 1CompletedTrillium Therapeutics Inc.282012-03-012013-06-26
Safety Study of LiRIS in Interstitial Cystitis (IC) Patients
LiRIS low dose and LiRIS high dose - Interstitial Cystitis
Phase 1CompletedAllergan182010-07-012014-11-25
Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis
capsaicin, Placebo - Interstitial Cystitis, Vulvar Diseases
Phase 1 / Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1391995-06-012025-05-04

Narrower conditions

Cystitis, Interstitial (5)  ·  Cystitis (1)  ·  Nocturia (1)  ·  Pain (1)  ·  Rare Diseases (1)  ·  Urogenital Diseases (1)  ·  Vulvar Diseases (1)  ·  Vulvar Vestibulitis (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Urinary Bladder Diseases (5)  ·  Urologic Diseases (5)  ·  Cystitis (4)  ·  Urogenital Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)

Interventions

Capsaicin (1)

Sponsors

Allergan (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Seikagaku Corporation (1)  ·  Trillium Therapeutics Inc. (1)  ·  UroGen Pharma Ltd. (1)

Countries

Canada (2)  ·  United States (2)  ·  Israel (1)

Top investigators

Amnon Zisman, MD (1)  ·  Curtis Nickel, MD (1)  ·  Hugh Flood (1)  ·  Penka Petrova, PhD (1)

NIH funding

R01DK049524 (1)